Vaccinology in sub-Saharan Africa

被引:10
作者
Moisi, Jennifer
Madhi, Shabir Ahmed [1 ,2 ]
Rees, Helen [2 ,3 ]
机构
[1] MRC, Dept Sci & Technol, South African Res Chair Initiat,Natl Res Fdn, Resp & Meningeal Pathogens Res Unit,Vaccine Preve, Johannesburg, South Africa
[2] Univ Witwatersrand, African Leadership Initiat Vaccinol Expertise, Johannesburg, South Africa
[3] Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa
关键词
capacity building; immunization; sub-saharan Africa; vaccinology;
D O I
10.1136/bmjgh-2018-001363
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We undertook a landscape analysis of vaccinology research and training in sub-Saharan Africa in order to identify key gaps and opportunities for capacity development in the field. We conducted interviews with regional and global immunisation experts, reviewed university and research centre websites, searched the scientific literature and analysed donor databases as part of our mapping exercise. We found that (1) few vaccinology training programmes are available in the region; (2) vaccinology research sites are numerous but unevenly distributed across countries and subregions and of widely varying capacity; (3) donor funding favours HIV, tuberculosis and malaria vaccine development over other high-burden diseases; (4) lack of vaccine design, manufacturing and regulatory capacity slows the progress of new vaccines through the research and development pipeline and (5) vaccine implementation research garners limited support. Regional efforts to strengthen African vaccinology expertise should develop advanced vaccinology training programmes, support clinical trial and implementation research sites in geographic areas with limited capacity and conduct multidisciplinary research to help design, license and roll out new vaccines.
引用
收藏
页数:7
相关论文
共 17 条
[1]  
[Anonymous], N ENGL J MED, DOI [10.1056/NEJMoa1710430, DOI 10.1056/NEJMOA1710430]
[2]  
[Anonymous], 10 FACTS POL ER
[3]  
[Anonymous], 2015, LANCET LONDON ENGLAN, V385, P117, DOI DOI 10.1016/S0140-6736(14)61682-2
[4]  
CEPI, 2019, NEW VACC SAF WORLD
[5]  
Daily S., 2016, SLEEPING SICKNESS CH
[6]   Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1+1) compared with two primary doses and a booster (2+1) in UK infants: a multicentre, parallel group randomised controlled trial [J].
Goldblatt, David ;
Southern, Jo ;
Andrews, Nick J. ;
Burbidge, Polly ;
Partington, Jo ;
Roalfe, Lucy ;
Pinto, Marta Valente ;
Thalasselis, Vasilli ;
Plested, Emma ;
Richardson, Hayley ;
Snape, Matthew D. ;
Miller, Elizabeth .
LANCET INFECTIOUS DISEASES, 2018, 18 (02) :171-179
[7]  
Gov.uk, 2016, UK VACC NETW
[8]   Cholera Outbreaks in Africa [J].
Mengel, Martin A. ;
Delrieu, Isabelle ;
Heyerdahl, Leonard ;
Gessner, Bradford D. .
CHOLERA OUTBREAKS, 2014, 379 :117-144
[9]  
Ministerial Conference on Immunization in Africa, 2018, ADD DECL IMM
[10]   When less is more: how many doses of PCV are enough? [J].
O'Brien, Katherine L. .
LANCET INFECTIOUS DISEASES, 2018, 18 (02) :127-128